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AbstrACt
Objective Low back pain (LBP) is a major problem in 
modern society and it is important to study possible risk 
factors for this disorder. People with diabetes are often 
affected by LBP, but whether diabetes represents a risk 
factor for LBP has not been studied in detail. The aim of 
this study was to explore the association between diabetes 
and subsequent risk of chronic LBP.
Design An 11-year follow-up study.
setting The Nord-Trøndelag Health Study (HUNT2; 1995–
1997) and HUNT3 (2006–2008) surveys of Nord-Trøndelag 
County in Norway.
Main outcome measure Chronic LBP, defined as LBP 
persisting at least 3 months continuously during the last 
year.
Participants A total of 18 972 persons without chronic 
LBP at baseline in HUNT2, and 6802 persons who reported 
chronic LBP at baseline in HUNT2.
Methods Associations between diabetes and risk of 
chronic LBP among individuals aged 30–69 years were 
examined by generalised linear modelling.
results Men without chronic LBP at baseline showed 
a significant association between diabetes and risk of 
chronic LBP (relative risk (RR) 1.43, 95% CI 1.04 to 
1.96, p=0.043). In women, no association was found 
(RR 1.01, 95% CI 0.69 to 1.48, p=0.98). No association 
could be established between diabetes and recurrence or 
persistence of chronic LBP after 11 years in either sex.
Conclusions Men with a diagnosis of diabetes may have 
a higher risk of subsequently experiencing chronic LBP.
IntrODuCtIOn
Low back pain (LBP) constitutes a signifi-
cant health problem in today’s society1 and it 
is important to explore possible risk factors 
associated with the disorder. Diabetes is 
increasing in prevalence worldwide, with 
possible serious implications.2 An association 
between diabetes and LBP has been indi-
cated in some population studies.3 4 Other 
studies have suggested a relationship between 
increased blood glucose levels and LBP.5 6 It 
has also been suggested that lumbar spinal 
stenosis may be associated with diabetes 
mellitus.7
Animal models have supported the exis-
tence of an association between type 2 diabetes 
and structural spinal changes8 and between 
a prediabetic state and spinal degenerative 
changes in the vertebral structure.9 Moreover, 
LBP and diabetes have important risk factors 
in common, as overweight and obesity,10 11 
physical inactivity12 13 and smoking.14 15
Few epidemiological studies have looked at 
relations between diabetes and back pain.16 
In a recently published study, women who 
experienced chronic LBP were found to have 
an increased risk of being diagnosed with 
diabetes in the subsequent 11-year interval.17 
Very few studies have considered diabetes as 
a risk factor for LBP. An association between 
prevalence of chronic LBP and diabetes was 
observed in a large cross-sectional study.18 In 
a 4-year longitudinal study, a higher risk of 
back, neck and/or shoulder pain was found 
among individuals with diabetes.19 A study 
of twins found that back pain was associated 
with the prevalence of diabetes, but diabetes 
did not significantly increase the risk of back 
pain in a follow-up of 2–4 years.3 Among 
patients having a diagnosis of either type 1 or 
type 2 diabetes, markers of increased diabetes 
disease burden were associated with the pres-
ence of back pain.20
strengths and limitations of this study
 ► The study is prospective with a long follow-up peri-
od of 11 years.
 ► The target population represents an entire 
Norwegian county in the relevant age range.
 ► The information about low back pain is self-reported 
in a questionnaire.
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Figure 1 Flow chart for the study. HUNT, Nord-Trøndelag 
Health Study; LBP, low back pain.
The objective of the current study was to explore rela-
tionships between diabetes and risk of chronic LBP in 
a Norwegian population, adjusting for established risk 
factors. The following questions are addressed. Among 
individuals without chronic LBP, does the risk of chronic 
LBP experienced after 11 years depend on having diabetes 
at start of follow-up? Among those with chronic LBP at 
start of follow-up, does diabetes increase the probability 
of recurrence or persistence of chronic LBP at the end of 
the 11-year follow-up period? The same data set has previ-
ously been used to study risk of chronic LBP depending 
on body mass index (BMI),10 several measures of body 
size21 and physical activity level in leisure time.12
MethODs
basic information
Three consecutive health surveys have been conducted in 
Nord-Trøndelag County in Norway22: the Nord-Trøndelag 
Health Study (HUNT1) in 1984–1986, HUNT2 in 1995–
1997 and HUNT3 in 2006–2008. This work combines 
baseline data from the second survey, HUNT2,23 with 
follow-up data from the third survey, HUNT3.22 All resi-
dents of the county aged 20 years and above were invited 
to take part in the HUNT2 survey. They were requested 
to complete a questionnaire on health status, and they 
were invited to a clinical consultation, including measure-
ment of height and weight. In the HUNT3 survey 11 years 
later, similar information was collected using a question-
naire and a clinical examination. Each participant in the 
HUNT2 and HUNT3 surveys signed a written informed 
consent regarding the collection and use of data for 
research purposes.
One question in the HUNT2 and HUNT3 question-
naires was expressed in this way: ‘During the last year, 
have you suffered from pain and/or stiffness in your 
muscles and joints that has lasted for at least 3 consec-
utive months?’ Each participant answering yes was given 
the following question: ‘Where did you have these 
complaints?’ Several body regions were listed. Individ-
uals answering yes to the first question and including the 
lower back as a relevant region were regarded as having 
chronic LBP.24
Another question in the HUNT2 questionnaire was: 
‘Do you have or have you had diabetes?’ The self-report 
had excellent positive (96.4%) and negative (99.7%) 
predictive values in a validation study comparing self-re-
ported diabetes in HUNT1 with records of general 
practitioners.25 The participants in HUNT2 also gave 
information regarding physical activity in leisure time 
and smoking, and information needed for determining 
Hospital Anxiety and Depression Scale (HADS) scores.26
study design
Because of lower participation rate in relatively large 
parts of the youngest and oldest age groups invited,27 
this study was restricted to respondents aged 30–69 years 
when they participated in HUNT2. Information about 
residence status was obtained from national registries 
and linked using the unique Norwegian personal identi-
fication numbers. At the time of the HUNT2 survey, the 
total population consisted of 58 928 persons in the age 
interval of 30–69 years (figure 1). An 11-year prospective 
study was carried out using baseline data from HUNT2 in 
combination with follow-up data from HUNT3. The study 
aimed at the cohort consisting of 45 157 individuals with 
information about presence or absence of chronic LBP 
and diabetes in HUNT2. This cohort included 33 250 
individuals without chronic LBP in HUNT2 and 11 907 
individuals with chronic LBP in HUNT2.
During the period of follow-up, 2761 members of 
this cohort died and 1567 individuals left the county 
of Nord-Trøndelag (figure 1). Furthermore, 15 055 
members of the cohort residing in Nord-Trøndelag at 
the time of HUNT3 did not participate or did not supply 
information about chronic LBP. Thus, a total of 25 774 
individuals could be considered in the prospective study, 
including 18 972 individuals in the analysis of risk among 
those initially free of chronic LBP, and 6802 individuals 
in the analysis of recurrence or persistence of chronic 
LBP among those with chronic LBP at baseline. The total 
number represented 63.1% of the remaining individuals 
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Table 1 Number of individuals included in the study of risk 











Age at baseline (year)
  30–39 2819 552 (19.6) 2106 305 (14.5)
  40–49 3317 710 (21.4) 2883 464 (16.1)
  50–59 2513 495 (19.7) 2366 316 (13.4)
  60–69 1601 348 (21.7) 1367 190 (13.9)
BMI at baseline (kg/m2)
  ≤24.9 4820 911 (18.9) 2837 355 (12.5)
  25–29.9 3892 846 (21.7) 4715 708 (15.0)
  30–34.9 1178 258 (21.9) 1019 188 (18.4)
  ≥35 334 85 (25.4) 128 21 (16.4)
Diabetes
  Absent 10 134 2082 (20.5) 8562 1244 (14.5)
  Present 116 23 (19.8) 160 31 (19.4)
BMI, body mass index; HUNT, Nord-Trøndelag Health Study; LBP, 
low back pain.
Table 2 Associations between diabetes at baseline and 
risk of chronic LBP in HUNT3, among individuals without 
chronic LBP at baseline
Women Men
Adjustment for age
  RR (95% CI) 0.95 (0.66 to 1.37) 1.38 (1.00 to 1.90)
  P value 0.78 0.07




Adjustment for age and BMI
  RR (95% CI) 0.92 (0.63 to 1.32) 1.34 (0.97 to 1.84)
  P value 0.63 0.097





  RR (95% CI) 1.01 (0.69 to 1.48) 1.43 (1.04 to 1.96)
  P value 0.98 0.043




*Adjustment for baseline age, BMI, physical activity and 
smoking.
BMI, body mass index; HUNT, Nord-Trøndelag Health Study; 
LBP, low back pain; RR, relative risk.
Covariates
Baseline age was represented by 10-year intervals in the 
main statistical analyses. BMI, defined as weight/height2, 
in kg/m2, was subdivided into four groups with limits 
consistent with the standard WHO definitions (except for 
categories at the extreme ends): ≤24.9, 25–29.9, 30–34.9 
and ≥35. For physical activity in leisure time, including 
going to work, one category represented light activity only 
or hard physical activity (leading to sweating or being out 
of breath) less than 1 hour/week. Other categories repre-
sented hard physical activity 1–2 hours/week, and 3 or 
more hours/week. The information collected on hard 
activity in leisure time showed acceptable repeatability in 
a reliability and validity study, and seemed to be a reason-
ably valid measure of vigorous activities.28 Categories of 
cigarette smoking represented current daily smoking, 
previous daily smoking and never daily smoking.
statistical analyses
Associations between diabetes and risk of chronic LBP 
were assessed by generalised linear modelling for bino-
mial observations with a log link, with adjustment 
for potential confounders. In view of sex contrasts in 
overall risk and in associations of other risk factors with 
diabetes29 and LBP,30 all analyses were performed sepa-
rately for women and men. In the main analyses, all vari-
ables adjusted for were regarded as categorical. Initial 
analyses involved adjustment for age only, and adjust-
ment was then added for other factors known to affect 
both the risk of LBP and diabetes, as BMI,11 16 31 physical 
activity in leisure time12 13 and smoking.14 15 Separate tests 
were carried out for interaction between diabetes and 
each factor adjusted for. Age and BMI were considered as 
continuous variables with a potential effect represented 
by a cubic polynomial in separate sensitivity analyses with 
more detailed adjustment.
Because information on potential confounders was 
missing in a minor part of the data set, analyses with 
complete adjustment included a slightly lower number 
of individuals than the age-adjusted analyses. The total 
number of individuals considered in each analysis is 
indicated in the tables. The overall HADS scores were 
available only for 87% of the individuals included in the 
analyses, and few individuals had high scores. For this 
reason, additional adjustment for HADS score was only 
performed in separate sensitivity analyses, with the score 
regarded as a continuous variable.
All statistical analyses were carried out using IBM SPSS 
V.25 (IBM).
Patient and public involvement
There was no patient or public involvement in the design 
or implementation of this study.
results
In the cohort study of individuals without LBP at baseline, 
a total of 2105 women (20.5%) and 1275 men (14.6%) 
reported chronic LBP at end of follow-up. The crude 
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Table 3 Number of individuals included in the study of 
recurrence/persistence of chronic LBP, among individuals 









Age at baseline (year)
  30–39 772 412 (53.4) 427 203 (47.5)
  40–49 1214 735 (60.5) 879 461 (52.4)
  50–59 1285 786 (61.2) 905 431 (47.6)
  60–69 755 471 (62.4) 565 247 (43.7)
BMI at baseline (kg/m2)
  ≤24.9 1615 903 (55.9) 854 407 (47.7)
  25–29.9 1630 976 (59.9) 1495 709 (47.4)
  30–34.9 569 379 (66.6) 370 192 (51.9)
  ≥35 205 139 (67.8) 54 32 (59.3)
Diabetes
  Absent 3958 2359 (59.6) 2726 1316 (48.3)
  Present 68 45 (66.2) 50 26 (52.0)
BMI, body mass index; HUNT, Nord-Trøndelag Health Study; 
LBP, low back pain.
Table 4 Associations between diabetes at baseline and 
recurrence/persistence of chronic LBP in HUNT3, among 
individuals with chronic LBP at baseline
Women Men
Adjustment for age
  RR (95% CI) 1.09 (0.92 to 1.29) 1.13 (0.86 to 1.48)
  P value 0.37 0.41




Adjustment for age and BMI
  RR (95% CI) 1.06 (0.90 to 1.26) 1.08 (0.82 to 1.42)
  P value 0.51 0.59





  RR (95% CI) 1.05 (0.87 to 1.27) 1.09 (0.83 to 1.43)
  P value 0.61 0.54




*Adjustment for baseline age, BMI, physical activity and 
smoking.
BMI, body mass index; HUNT, Nord-Trøndelag Health Study; 
LBP, low back pain; RR, relative risk.to any major extent on age (table 1). The percentage of 
LBP at end of follow-up was greater in men with diabetes 
than in those without (table 1), but no such tendency was 
present among women.
In the corresponding analysis with complete adjust-
ment, a statistically significant association was found 
among men between baseline diabetes and risk of chronic 
LBP in HUNT3 (table 2). Men with diabetes experienced 
43% increased risk of chronic LBP at end of the 11-year 
follow-up. No association between diabetes and risk of 
chronic LBP was indicated in women (table 2), but the 
sex difference in associations was not statistically signifi-
cant (p=0.17).
In the study of recurrence/persistence of chronic LBP, 
among persons with chronic LBP at baseline, a total of 
2404 women (59.7%) and 1342 men (48.3%) experi-
enced chronic LBP at follow-up (table 3). The percentage 
of individuals with chronic LBP in HUNT3 was some-
what larger among those reporting diabetes at baseline, 
in particular among women. However, in the analyses 
adjusted for other risk factors, no excess probability of 
LBP could be established among individuals with diabetes 
and chronic LBP at baseline (table 4).
No significant interaction between diabetes and any of 
the covariates was found. Analyses carried out with adjust-
ment for age and BMI as continuous variables revealed 
no particular change in the risk estimates associated with 
diabetes. Additional adjustment for HADS score hardly 
changed the associations between diabetes and risk or 
recurrence/persistence of LBP in analyses including 
the individuals with known HADS scores. Thus, adding 
adjustment for HADS to the complete model of risk of 
LBP considered for men produced a relative risk of 1.61 
(95% CI 1.17 to 2.23) among the 7826 individuals with 
information available, compared with a relative risk of 
1.58 (95% CI 1.14 to 2.19) without adjustment for HADS 
among exactly the same set of individuals.
DIsCussIOn
In this cohort, an increased risk of chronic LBP was 
found in men with diabetes. In women, no association 
was observed between diabetes and risk of chronic LBP. 
Among persons with chronic LBP at start of follow-up, 
no association between diabetes and recurrence or 
persistence of chronic LBP after 11 years could be estab-
lished in either sex.
A major strength of our study is the use of a large 
population-based data set collected in an entire county, 
with the great majority of the individuals belonging to a 
uniform ethnic group.23 Socioeconomic differences in 
this population are small. The area studied is representa-
tive of Norway, but does not include any major city. The 
total follow-up period of 11 years was substantially longer 
than in comparable cohort studies.3 19
Our study has several limitations. Diabetes diagnoses 
were based on self-reports in a questionnaire, but a 
validity study25 indicated that the information supplied by 
the participants on such diagnoses was largely consistent 
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proportion of those with diabetes have not received a 
formal diagnosis.32 If the failure to detect diabetes cases 
occurs at random, a true positive association with LBP will 
only be slightly attenuated. If, on the other hand, those 
without a formal diagnosis tend to have a lower risk of 
LBP, a positive bias may be created. Characteristics such 
as diabetes type or duration and use of medication were 
not taken into account in our analysis. An earlier study 
using cross-sectional HUNT data considering diabetes 
and migraine33 reported that the great majority of the 
diagnoses were likely of type 2 diabetes. Classical type 1 
diabetes constituted about 6% and latent autoimmune 
diabetes of adults about 5% of all cases of diabetes. The 
diagnosis of chronic LBP in our study was also based on 
self-reports and only referred to the last year before each 
questionnaire was returned. Unfortunately no informa-
tion was available about LBP in the remainder of the 
intervening period, complicating the exact definitions 
of recurrence or persistence. Moreover, with additional 
information on pain intensity, a more precise definition 
of chronic LBP could have been established.34 In any case, 
our results only apply to the age interval of 30–69 years at 
baseline, and no statements can be made in connection 
with diabetes diagnosed from the age of 70 years.
Although response rates in HUNT2 were relatively high, 
response rates were lower in the subsequent HUNT3 
study, and minor parts of the cohort were lost because of 
death or movement out of the county. This will not affect 
the magnitude of relative risk estimates if loss to follow-up 
or participation rates at end of follow-up only depend 
on baseline diabetes status. However, such loss may be 
important if participation rates are associated with LBP to 
a different extent within categories of baseline diabetes 
status. Chronic LBP is a serious condition but is far from 
life threatening, so a major influence of this kind seems 
less likely. In particular, it is not to be expected that a bias 
of this kind should generate a false-positive association 
between diabetes and LBP within the age range consid-
ered. Individuals with a diabetes diagnosis may be more 
frequently in contact with the healthcare system, but LBP 
is not normally a medical condition that is detected unex-
pectedly on such occasions.
The statistical analysis of our data set was made more 
complicated by the fact that the category with diabetes 
at baseline constituted a relatively small fraction of the 
entire population at risk. Thus, the number of individuals 
in this category with LBP at follow-up was low, which made 
detailed analyses with more extensive adjustment for 
other potential risk factors difficult. Previous studies using 
HUNT data have found that BMI is strongly associated to 
both LBP10 and diabetes,35 and thus BMI is an important 
potential confounder. However, adjustment specifically 
for BMI led to only minor changes in risk estimates. BMI 
was grouped into four categories representing normal 
weight or underweight, overweight, obesity and severe 
obesity. Separate analyses with BMI regarded as a contin-
uous variable did not indicate that residual confounding 
represented any major problem. Several other potential 
confounders of an association between diabetes and LBP 
showed only moderate variation between individuals in 
the particular population considered. Thus, socioeco-
nomic status is largely uniform, and access to medical 
treatment is standardised in the public Norwegian health-
care system, including the entire population.
We were only able to adjust for HADS score in partic-
ular sensitivity analyses of a subset of the individuals 
considered. The estimated relationship between diabetes 
and risk of LBP among men was somewhat stronger in 
this subset, and it is possible that the individuals included 
were not entirely representative of the complete data 
set. Yet adjustment for HADS score did not weaken the 
relationship. It is still conceivable that confounding due 
to variables not adjusted for, in particular psychosocial 
factors incorporating other kinds of information, might 
affect relative risk estimates.
Among the few similar studies, a higher risk of back, 
neck and/or shoulder pain was found among men with 
diabetes in a large Swedish 4-year follow-up.19 A 2–4 years’ 
follow-up of Spanish twins did not provide evidence that 
type 2 diabetes increases the risk of back pain, although 
higher OR estimates were found in men when diabetes 
was investigated as a risk factor for severe chronic LBP.3 
A cross-sectional study in the USA using data from the 
National Health and Nutrition Examination Survey 
found higher prevalence of chronic LBP among partic-
ipants with diabetes.18 Other kinds of studies have found 
mixed results concerning possible associations between 
diabetes and back pain. In data from the TwinsUK cohort, 
an association between type 2 diabetes and lumbar inter-
vertebral disc degeneration disappeared after adjustment 
for BMI.36 In a Finnish cross-sectional study an association 
was found between chronic widespread pain including 
back pain and both diabetes and pre-diabetes.37 The prev-
alence of musculoskeletal pain including LBP was signifi-
cantly higher in a Danish study of patients with type 2 
diabetes matched against the general population.38 In a 
Norwegian follow-up study, increased risk of hip fractures 
was found among women with diabetes.39
An increased risk of chronic LBP in men with diabetes, 
as observed in our study, could be caused by shared risk 
factors between diabetes and LBP. However, considering 
the adjustment introduced here for BMI, physical activity 
and smoking, this seems less likely. It is also possible 
that diabetes has led to increased BMI and less physical 
activity during follow-up, and in this way an increased 
risk of chronic LBP. LBP has been associated with dyslip-
idaemia,40 41 with atherosclerosis in the feeding arteries 
producing impaired blood flow to the lower back and 
possibly lumbar disc degeneration.42 Dyslipidaemia is 
related to insulin resistance and type 2 diabetes.43 Inflam-
mation may also be related to both LBP44 and diabetes.45 
The possibility that other kinds of comorbidity may 
affect the association between diabetes and LBP cannot 
be excluded, but it is not obvious whether the medical 
conditions involved would be part of a causal pathway 
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In our data set, those who had chronic LBP at baseline 
in HUNT2 also had a much higher probability of chronic 
LBP at end of follow-up in HUNT3, but this probability 
did not depend on diabetes status at baseline. Few studies 
have explicitly addressed associations between risk factors 
and recurrence or persistence of LBP.10 46–48 In a recent 
study among the HUNT population, women but not men 
who experienced chronic LBP were found to have an 
increased risk of being diagnosed with diabetes after 11 
years.17 The sex difference reported in that study is not 
necessarily inconsistent with the present results, because 
the risk factor and the disease examined are exchanged. 
A difference in risk estimates between women and men 
was also found in the longitudinal analysis of LBP as a 
risk factor for type 2 diabetes in the Spanish twin study.3 
It is known that there are general gender differences in 
noticing pain,49 50 which may affect the prevalence of LBP. 
Different levels of sex hormones may also lead to gender 
differences in associations with risk factors.29
Diabetes is known to be associated with a number of 
complications and a higher risk of other diseases as poly-
neuropathy, kidney and cardiovascular diseases. The 
results of this study indicate that chronic LBP might be 
considered another candidate for this list of associated 
disorders in men.
COnClusIOns
Men with diabetes may have a higher risk of chronic 
LBP. In women, no association has been established. 
These results need to be confirmed in studies from other 
populations.
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